FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/05/2024
Voltar para busca
Dado oficial do USPTO
ECTOVIR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
13/05/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 10
Data de depósito
07/05/2021
Data de registro
23/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/01/2024
Última transação
23/01/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
09
Localização do titular
DE
Examinador
OSGOOD, KRYSTINA
Unidade examinadora
N30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
bitop Aktiengesellschaft (bitop AG)
Representantes
Robert S. Broder Collard & Roe, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical substanceschemical materialschemical preparations and natural elementsin particular biological preparations for use in industry and science; biological preparations for use in industry; biological preparations for use in science; chemical substances for use as adsorbents for inhalant gases for analyses in laboratoriesother than for medical or veterinary purposes; propellant gases for aerosols; preservatives for use in pharmaceutical preparations; none of the aforementioned are related to the development of skin care products
Classe 5
Medical and veterinary preparations and articlesantiviral and anti-inflammatory substances which preventdetectmonitor or alleviate respiratory diseases; medical and veterinary preparations and articlesmedicaments and natural remedy preparations for the treatment of respiratory diseasessuch as viral infection and inflammation; biological adjuvants for medical purposes; chemical adjuvants for medical purposes; eye drops; anti-inflammatory gels; anti-inflammatory preparations; anti-inflammatory sprays; gases for medicinal purposes; inhalation preparationsinhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; solutions for medicinal purposes for washing the nasal passagesnasal rinse; medicated lozenges; medicated mouthwashes; medicated ointments in the nature of medicated lotions for application to the mucous membrane; medicated spraysmedicated eye sprays; medicated throat sprays; nasal sprays for medical purposes; nasal drops for the treatment of viral and respiratory diseasessuch as infection and inflammation; pharmaceutical preparations and substances having anti-inflammatory propertiesanti-inflammatory dropssprays and ointments for use in eyes and upper respiratory tract; pharmaceutical being medicated throat sprays; decongestant sprays for decongesting the mucous membrane of the nose; medicated throat sprays for use in the throat; nose drops for medical purposes; sanitary preparations for medical purposes; sanitary preparations and articlesin particular medicated eye washes; none of the aforementioned are related to the development of skin care products
Classe 10
Medical and veterinary apparatus and instrumentsexternal fixators; medical and veterinary apparatus and instrumentsin particular aerosol dispensers for medical purposes; eye bathseye wash cups for medical purposes; eye wash cups for medical purposes; eye drop guides; humidifiers for medical purposes; humidifiers for use with respiratory therapy apparatus for medical use; electric nasal irrigators; electric vaporizers for administering steam inhalants for upper respiratory conditions; electric nebulizers for medical purposes; chambers for inhalers; inhalers for medical use; inhalers for the administration of medicaments for medical use; inhalers for medical purposessold empty; inhalers for the vaporization of para-medical substances for medical purposes; medical apparatus to facilitate the inhalation of pharmaceutical preparationsinhalers for medical purposes; medical inhalers; nasal irrigatorselectric; non-electric nasal irrigators; aerosol cans being aerosol dispensers for medical purposes; spray bottlesvaporizers for medical use; hand sprayershand operatedfor cleaning gums and teeth used in dentists' offices during dentist procedures for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
24/04/2024
FIMP
FINAL DISPOSITION PROCESSED
24/04/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/04/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/04/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
23/01/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
23/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/11/2023
PUBO
PUBLISHED FOR OPPOSITION
07/11/2023
GPNX
NOTIFICATION PROCESSED BY IB
06/11/2023
EXPT
EXPARTE APPEAL TERMINATED
02/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/10/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
18/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/09/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/09/2023
ALIE
ASSIGNED TO LIE
08/09/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
25/04/2023
EXPI
EX PARTE APPEAL-INSTITUTED
25/04/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
25/04/2023
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
25/04/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/03/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
23/03/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
23/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/03/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
14/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/02/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
22/02/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
25/10/2022
GNFR
FINAL REFUSAL E-MAILED
25/10/2022
CNFR
FINAL REFUSAL WRITTEN
25/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/08/2022
RFNT
REFUSAL PROCESSED BY IB
28/02/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/02/2022
RFRR
REFUSAL PROCESSED BY MPU
07/02/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/01/2022
CNRT
NON-FINAL ACTION WRITTEN
14/01/2022
DOCK
ASSIGNED TO EXAMINER
12/01/2022
MAFR
APPLICATION FILING RECEIPT MAILED
01/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/09/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/09/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ECTOVIR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.